PolyMASC Pharmaceuticals plc

PolyMASC Pharmaceuticals plc is a young biopharmaceutical company whose shares were admitted to trading on the Alternative Investment Market (AIM) of the London Stock Exchange in December 1995.
The Company develops and licenses out proprietary formulation technologies, therapeutics and biodiagnostic agents. The formation of PolyMASC combines the well established research team, formerly of the Molecular Cell Pathology Laboratory of the Royal Free Hospital School of Medicine, University of London, with a highly experienced commercial team that has extensive experience in the pharmaceutical industry.
PolyMASC is a wholly owned subsidiary of Valentis, Inc

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Diagnostics
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: